Mission Statement
Mission Statement
Embedded Files
We are interested in fundamental and translational aspects of lipid metabolism in nutrition-related chronic diseases. In particular, how dietary (intestinal) derived lipids and their metabolism contribute to, or alleviate pathways that cause cardiovascular etiology.
We are keen to appreciate how the etiology of early obesity, insulin resistance and Type 2 diabetes accelerates CVD complications and influence lipid homeostasis. Our dynamic and vibrant group fosters a supportive research environment for staff/trainees in order to build capacity and facilitate unique inter-disciplinary scientific training.
Participants Needed
Participants Needed
Latest News
Latest News
PCOS has a new name!
PCOS has a new name!
Polyendocrine Metabolic Ovarian Syndrome (PMOS) is the new name for the condition previously known as Polycystic Ovary Syndrome (PCOS), which impacts 1 in 8, or more than 170 million women worldwide.
In our Pathways to Care for PCOS-PMOS in Alberta, assessing cardiometabolic risk at diagnosis is key to better care for those with PMOS (see link to PMOS Website).
The new name, Polyendocrine Metabolic Ovarian Syndrome (PMOS), has just been published in The Lancet and is being announced currently at the European Congress of Endocrinology Conference May 2026.
Here are some resources and videos for you to share with your networks – https://bit.ly/3V85nPJ. There are patient and health professionals resources that have been translated in English, Arabic, Persian, Mandarin, German, Spanish, Portuguese, French, and other languages.
For more information: https://www.mchri.org.au/guidelines-resources/community/pcos-resources-2
PCOS/PMOS Patient Partner Featured at Ceremony for Largest Gift in UofA History for Women’s and Children’s Health
PCOS/PMOS Patient Partner Featured at Ceremony for Largest Gift in UofA History for Women’s and Children’s Health
Sarah Chambers knows this feeling too well. After the Edmonton resident was diagnosed with polycystic ovary syndrome (PCOS/PMOS), her family doctor didn’t have much medical advice to share beyond what would be useful if she were trying to have a baby.
WCHRI researcher Donna Vine, however, has upended the misconception that PCOS/PMOS is mainly a reproductive condition. After finding that women with PCOS are three times more likely to develop diabetes and cardiovascular disease, Vine is now operating clinical trials with patients from the Lois Hole Hospital for Women to establish methods of detecting and treating these diseases.
Learn more about how WCHRI is transforming lives to help women and children thrive
Congrats Eden!
Agricultural, Food and Nutritional Science: Annual Report 2024-25
The 2025-2026 RIP Seminar Series will be continuing with a presentation by Dr. Caroline Richard
Title: Understanding the obesity-related immune dysfunction: findings from the NutrIMM study
This Women’s Health Research Month, we are celebrating two decades of the Women and Children’s Health Research Institute!
For 20 years, WCHRI and its partners, including the @abwomenshealthfoundation , have funded the research that matters most to women. By supporting experts like Donna Vine, we are bridging the research gap and turning laboratory discoveries into better clinical care for women in Alberta and beyond.
Join our “PCOS Together & MCVD Lab Team” to participate in the Shoppers Drug Mart® Run for Women, Sir Wilfrid Laurier Park (13221 Buena Vista Rd NW, Edmonton, AB), May 23, 2026, starting at 8:30am for Team Photos
https://raceroster.com/registration/e04e364d-c3cf-49cd-ba92-a3ac133e3af8/entry?team=950834
Your registration includes:
An event T-shirt
Our signature swag bag
A finisher’s bracelet to wear with pride
Meet us for Team photos at 8:30am by the PCOS Together's 6 floot flag, close to the Registration Tent
Recent Publications
Recent Publications
Page updated
Report abuse